pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
545
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
empasiprubart
Multifocal Motor Neuropathy
$ARGX
ARGENX SE
0
catalysts
Phase 3
encaleret
Autosomal Dominant Hypocalcemia
$BBIO
BridgeBio Pharma, Inc.
0
catalysts
Phase 3
eneboparatide
Hypoparathyroidism
Alexion Pharmaceuticals Inc
0
catalysts
Phase 3
← prev
page 10 of 19
next →
131
Pain
89
Neurology
1
enlicitide decanoate
Heterozygous Familial Hypercholesterolemia (heFH)
$MRK
Merck & Co., Inc.
0
catalysts
Phase 3
entolimod
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
Toll-like receptor 5
$TIVC
Tivic Health Systems, Inc.
0
catalysts
Phase 3
envudeucitinib
Plaque Psoriasis (Psoriasis Vulgaris)
$ALMS
ALUMIS INC.
0
catalysts
Phase 3
ercanetide
ercanetide [INN]
Phelan-McDermid Syndrome (22q13.3 Deletion Syndrome)
Neuren Pharmaceuticals Ltd
0
catalysts
Phase 3
ersodetug
Hypoglycemia
$RZLT
Rezolute, Inc.
0
catalysts
Phase 3
estetrol
Donesta (estetrol)
Vasomotor Symptoms of Menopause (Hot Flashes)
Estrogen receptor
Gedeon Richter Plc
0
catalysts
Phase 3
etalanetug
Dementia
Eisai Co Ltd
0
catalysts
Phase 3
etavopivat
Sickle Cell Disease
Pyruvate kinase PKLR
Novo Nordisk AS
0
catalysts
Phase 3
etentamig
Refractory Multiple Myeloma
$ABBV
AbbVie Inc.
0
catalysts
Phase 3
evenamide
evenamide [INN]
Schizophrenia
Newron Pharmaceuticals SpA
0
catalysts
Phase 3
evorpacept
Adenocarcinoma Of The Gastroesophageal Junction
Leukocyte surface antigen CD47
$ALXO
ALX ONCOLOGY HOLDINGS INC
0
catalysts
Phase 3
exagamglogene autotemcel
Casgevy (exagamglogene autotemcel)
Beta Thalassaemia
B-cell lymphoma/leukemia 11A
$VERX
Vertex, Inc.
0
catalysts
Phase 3
fasedienol
Aloradine (fasedienol)
Social Anxiety Disorder (SAD/Social Phobia)
$VTGN
Vistagen Therapeutics, Inc.
0
catalysts
Phase 3
fazirsiran sodium
Alpha-1 Antitrypsin Deficiency (A1AD)
$ARWR
ARROWHEAD PHARMACEUTICALS, INC.
0
catalysts
Phase 3
felzartamab
felzartamab [INN]
Membranous Glomerulonephritis
$BIIB
BIOGEN INC.
0
catalysts
Phase 3
fenebrutinib
Primary Progressive Multiple Sclerosis (PPMS)
Tyrosine-protein kinase BTK
Genentech Inc
0
catalysts
Phase 3
fianlimab
Metastatic Melanoma
Lymphocyte activation gene 3 protein
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts
Phase 3
ficerafusp alfa
Recurrent Head And Neck Squamous Cell Carcinoma
$BCAX
Bicara Therapeutics Inc.
0
catalysts
Phase 3
ficlatuzumab
Recurrent Head And Neck Squamous Cell Carcinoma
Hepatocyte growth factor
AVEO Pharmaceuticals Inc
0
catalysts
Phase 3
florensocatib
Bronchiectasis
Chiesi Farmaceutici SpA
0
catalysts
Phase 3
fosmanogepix
Unspecified Fungal Infections
GPI-anchored wall transfer protein 1
Basilea Pharmaceutica Ltd
0
catalysts
Phase 3
freneslerbart + mevonlerbart
Cat Allergy
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts
Phase 3
frexalimab
Relapsing Remitting Multiple Sclerosis (RRMS)
$SNY
Sanofi
0
catalysts
Phase 3
furmonertinib mesylate
Non-Small Cell Lung Cancer
$AVBP
ArriVent BioPharma, Inc.
0
catalysts
Phase 3
galinpepimut-S
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Wilms tumor protein
$SLS
SELLAS Life Sciences Group, Inc.
0
catalysts
Phase 3
gavorestat
Neuromuscular Disorders
Applied Therapeutics Inc
0
catalysts
Phase 3
gildeuretinol acetate
Juvenile Macular Degeneration (Stargardt Disease)
Alkeus Pharmaceuticals Inc
0
catalysts
